Analyst Research

Report Title Price
Provider: BuySellSignals Research
$5.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: BuySellSignals Research
$5.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sun Pharmaceutical Industries Ltd's Subsidiary Announces Tentative USFDA Approvals For Generic Januvia And Generic Glumetza


Sunday, 14 Apr 2013 10:57pm EDT 

Sun Pharmaceutical Industries Ltd's Subsidiary announced that the US FDA has granted two tentative approvals for its Abbreviated New Drug Application (ANDA) for generic version of Januvia , Sitagliptin Tablets and generic version of Glumetza, Metformin HC extended release tablets. 

Company Quote

741.45
16.5 +2.28%
6:21am EDT